Abstract: The present invention relates to a biologically pure culture comprising an isolated Duddingtonia flagrans (D. flagrans) strain IAH 1297 deposited at the National Measurement Institute, 1/153 Bertie Street Port Melbourne, Victoria 3207, Australia on 2 Aug. 2016 (accession number V16/019156) and/or a spore of said isolated D. fiagrans strain, a composition comprising the same, methods and uses thereof.

Abstract: A method is provided for selecting an analgesic regime for treatment of a patient. In the method, a body fluid sample from the patient is assayed for the presence of a metabolite produced by metabolism of a prodrug. If the metabolite is present in the body fluid sample this indicates that a suitable analgesic regime for the patient should comprise administration of at least one analgesic agent selected from the group consisting of: codeine and tramadol. If the metabolite is absent from the body fluid sample indicates that a suitable analgesic regime for the patient should comprise administration of an analgesic agent selected from the group consisting of: dihydrocodeine; buprenorphine and propoxyphene. The invention also provides a kit for selecting an analgesic regime for a patient. The kit comprises means for assaying for the presence of a metabolite produced by metabolism of a prodrug and instructions for using the provided means to perform the method as described above.

Abstract: The present invention relates to a system for the intensive management of animals, the system comprising: animal identification means for identifying individual animals; at least one device for measuring one or more parameters of individual animals; a processor for processing measurements obtained for the one or more parameters, wherein the processed parameter data is used to determine management strategies for individual animals in real-time; and means for implementing management strategies for the animals.